Friday was an uneventful day for healthcare equities which finished the session lower overall, with Healthcare down (0.29%) versus the S&P 500 which gained +0.08%….
January 16, 2024
Medical diagnostics AI company Spectral AI, Inc. (Nasdaq: MDAI) has enrolled the first patient in a pivotal study to validate DeepView AI® using its proprietary…
January 12, 2024
Nexalin Technology HALO™ Clarity Device Offers Hope for Treating Mental Health Conditions
Nexalin Technology, Inc. (Nasdaq: NXL) has launched its Gen-3 HALO™ Clarity neurostimulation device designed to treat mental health conditions including Major Depressive Disorder (MDD), addiction…
January 09, 2024
PRISM MarketView Honors National Biotechnology Month with a Spotlight on Emerging Biotech Innovators
In celebration of National Biotechnology Month, PRISM MarketView acknowledges the significant advancements in biotechnology since its establishment by President Clinton in 2000. This month-long celebration…
Novartis Pharma (NYSE: NVS) and Eli Lilly and Co (NYSE: LLY) have entered into strategic research collaborations with Isomorphic Labs, a unit of Alphabet (Nasdaq:…
January 08, 2024
M&A Madness: Novartis Continues Buying Spree
Novartis (NYSE: NVS) remains at the center of January’s flurry of M&A activity after entering three different agreements on Monday. The Wall Street Journal also…
January 08, 2024
Merck Scoops Harpoon in $680M Deal
Harpoon Therapeutics, Inc. (Nasdaq: HARP) has agreed to be acquired by Merck (NYSE: MRK) in a cash deal valued at approximately $680 million. Harpoon’s share…
Clinical-stage biotechnology company, GeoVax Labs, Inc. (Nasdaq: GOVX), has completed patient enrollment for its Phase 1/2 clinical study evaluating Gedeptin® in patients suffering from advanced…
Shares in Omega Therapeutics, Inc. (Nasdaq: OMGA) have surged today following news that the company has entered a research partnership with Novo Nordisk ($NVO) to…
Lexaria Bioscience (Nasdaq: LEXX) has reported positive final results from a pilot study evaluating its DehydraTECHTM technology for the oral delivery of the GLP-1 drug…
January 04, 2024
ProMIS Neurosciences Replaces CEO, Gail Farfel
Biotechnology company, ProMIS Neurosciences Inc. (Nasdaq: PMN), has announced it will replace its current Chief Executive Officer, Gail Farfel with Neil Warma, a highly-qualified biotechnology…
January 04, 2024
ABVC BioPharma Shares Soar After $460M Payday
ABVC BioPharma, Inc. (Nasdaq: ABVC) and its subsidiary BioLite, Inc have received an aggregate of 46 million shares from AiBtl BioPharma Inc. as its first…